Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver

Authors

  • Jeonghoon Heo,

    1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD
    Search for more papers by this author
  • Valentina M. Factor,

    1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD
    Search for more papers by this author
  • Tania Uren,

    1. Laboratory of Hepatitis Viruses, Division of Viral Products, CBER/Food and Drug Administration, Bethesda, MD
    Search for more papers by this author
  • Yasushi Takahama,

    1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD
    Current affiliation:
    1. 1st Department of Surgery, Nara Medical University, Nara, Japan; Ju-Seog Lee is currently affiliated with the Department of Molecular Therapeutics, University of Texas, M.D. Anderson Cancer Center, Houston, TX
    Search for more papers by this author
  • Ju-Seog Lee,

    1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD
    Search for more papers by this author
  • Marian Major,

    1. Laboratory of Hepatitis Viruses, Division of Viral Products, CBER/Food and Drug Administration, Bethesda, MD
    Search for more papers by this author
  • Stephen M. Feinstone,

    1. Laboratory of Hepatitis Viruses, Division of Viral Products, CBER/Food and Drug Administration, Bethesda, MD
    Search for more papers by this author
  • Snorri S. Thorgeirsson

    Corresponding author
    1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD
    • Laboratory of Experimental Carcinogenesis, National Cancer Institute, 37 Convent Dr., Bldg. 37/Room 4146, Bethesda, MD 20892
    Search for more papers by this author
    • fax: 301-496-0734


  • Potential conflict of interest: Nothing to report.

Abstract

We established an efficient system for differentiation, expansion and isolation of hepatic progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to repopulate injured liver. Using mouse ES cells transfected with the green fluorescent protein (GFP) reporter gene regulated by albumin (ALB) enhancer/promoter, we found that a serum-free chemically defined medium supports formation of embryoid bodies (EBs) and differentiation of hepatic lineage cells in the absence of exogenous growth factors or feeder cell layers. The first GFP+ cells expressing ALB were detected in close proximity to “beating” myocytes after 7 days of EB cultures. GFP+ cells increased in number, acquired hepatocyte-like morphology and hepatocyte-specific markers (i.e., ALB, AAT, TO, and G6P), and by 28 days represented more than 30% of cells isolated from EB outgrowths. The FACS-purified GFP+ cells developed into functional hepatocytes without evidence of cell fusion and participated in the repairing of diseased liver when transplanted into MUP-uPA/SCID mice. The ES cell-derived hepatocytes were responsive to normal growth regulation and proliferated at the same rate as the host hepatocytes after an additional growth stimulus from CCl4-induced liver injury. The transplanted GFP+ cells also differentiated into biliary epithelial cells. In conclusion, a highly enriched population of committed hepatocyte precursors can be generated from ES cells in vitro for effective cell replacement therapy. (HEPATOLOGY 2006;44:1478–1486.)

Ancillary